. “Bioequivalence: The Regulatory Career of a Pharmaceutical Concept” . Bulletin of the History of Medicine. Submitted.
Journal Article
. “Approval Regulation and Endogenous Consumer Confidence: Theory and an Analogies to Licensing, Safety and Financial Regulation” . Regulation and Governance . 2010;4(4).
“Institutional Strangulation: Bureaucratic Politics and Financial Reform in the Obama Administration” . Perspective on Politics. 2010;8(3):825-46.
. “Early-Entrant Protection in Approval Regulation: Theory and Evidence from FDA Drug Review”. Journal of Law Economics and Organization . 2010;26(2).
. “U.S. Pharmaceutical Innovation in an International Context” . American Journal of Public Health [Internet]. 2010;(6):1075-1080. Website
. “Reputation Information and Confidence – The Political Economy of Pharmaceutical Regulation” . Public Choice and Public Law . 2010.
. “Drug Review Deadlines and Subsequent Safety Problems”. New England Journal of Medicine . 2008;358(13):1354-61.
. “A Formal Model of Learning and Policy Diffusion” . American Political Science Review . 2008;102 (3):319-32.
. “Policy Tragedy and the Emergence of Regulation: The Food Drug and Cosmetic Act of 1938” . Studies in American Political Development . 2007;21(2):149-180.
. “Regulatory Errors with Endogenous Agendas”. American Journal of Political Science . 2007;51(4):835-853.
- 1 of 4
- next ›